Emergent BioSolutions
EBS
#6766
Rank
NZ$1.09 B
Marketcap
NZ$20.60
Share price
-1.24%
Change (1 day)
32.42%
Change (1 year)

Emergent BioSolutions (EBS) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$1.14 Billion

According to Emergent BioSolutions 's latest financial reports the company's total debt is NZ$1.14 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Emergent BioSolutions - Total debt on balance sheet (from 2004 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$1.17 B-13.48%
2023-12-31NZ$1.36 B-38.57%
2022-12-31NZ$2.21 B79.83%
2021-12-31NZ$1.23 B1.55%
2020-12-31NZ$1.21 B0.64%
2019-12-31NZ$1.20 B1.69%
2018-12-31NZ$1.18 B6131.92%
2017-12-31NZ$19 M-95.09%
2016-12-31NZ$0.38 B7.29%
2015-12-31NZ$0.36 B12.61%
2014-12-31NZ$0.32 B324.6%
2013-12-31NZ$75.44 M-1.13%
2012-12-31NZ$76.3 M0.17%
2011-12-31NZ$76.17 M23.92%
2010-12-31NZ$61.47 M-32.06%
2009-12-31NZ$90.48 M-8.18%
2008-12-31NZ$98.53 M30.28%
2007-12-31NZ$75.63 M24.58%
2006-12-31NZ$60.71 M248.41%
2005-12-31NZ$17.42 M-3.37%
2004-12-31NZ$18.03 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Merck
MRK
NZ$71.61 B 6,139.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
NZ$1 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$41.30 B 3,498.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
NZ$4.53 M-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$105.32 B 9,076.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$29.55 B 2,474.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
NZ$0.66 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA